394 related articles for article (PubMed ID: 26568368)
1. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
2. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Am J Clin Nutr; 2015 Nov; 102(5):1207-15. PubMed ID: 26447153
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
4. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
J Nutr; 2016 Mar; 146(3):576-85. PubMed ID: 26817718
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
7. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
10. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
12. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
[TBL] [Abstract][Full Text] [Related]
13. Associations between fruit, vegetable and legume intakes and prostate cancer risk: results from the prospective Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort.
Diallo A; Deschasaux M; Galan P; Hercberg S; Zelek L; Latino-Martel P; Touvier M
Br J Nutr; 2016 May; 115(9):1579-85. PubMed ID: 26950824
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.
Brändstedt J; Almquist M; Ulmert D; Manjer J; Malm J
Cancer Causes Control; 2016 Jan; 27(1):69-80. PubMed ID: 26518197
[TBL] [Abstract][Full Text] [Related]
15. The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.
Atoum MF; AlKateeb D; AlHaj Mahmoud SA
Asian Pac J Cancer Prev; 2015; 16(6):2227-30. PubMed ID: 25824742
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
17. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians.
Vupputuri MR; Goswami R; Gupta N; Ray D; Tandon N; Kumar N
Am J Clin Nutr; 2006 Jun; 83(6):1411-9. PubMed ID: 16762954
[TBL] [Abstract][Full Text] [Related]
19. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
20. Effects of Genetic and Nongenetic Factors on Total and Bioavailable 25(OH)D Responses to Vitamin D Supplementation.
Yao P; Sun L; Lu L; Ding H; Chen X; Tang L; Xu X; Liu G; Hu Y; Ma Y; Wang F; Jin Q; Zheng H; Yin H; Zeng R; Chen Y; Hu FB; Li H; Lin X
J Clin Endocrinol Metab; 2017 Jan; 102(1):100-110. PubMed ID: 27768857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
